Currie, J. Brooke
81  Ergebnisse:
Personensuche X
?
 
?
2

MM-509 A Phase III, Open-Label, Randomized Study to Evaluat..:

Weisel, Katja ; Hungria, Vania T.M. ; Radinoff, Atanas...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S504-S505 , 2023
 
?
 
?
5

P-252 Impact of belantamab mafodotin vs pomalidomide/low-do..:

Dimopoulos, Meletios ; Weisel, Katja ; Hungria, Vania...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S174-S175 , 2023
 
?
6

POSTER: MM-510 Patient-Reported Outcomes in Patients With R..:

Hungria, Vania ; Weisel, Katja ; Currie, Brooke...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S224 , 2023
 
?
8

MM-510 Patient-Reported Outcomes in Patients With Relapsed ..:

Hungria, Vania ; Weisel, Katja ; Currie, Brooke...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S505 , 2023
 
?
 
?
10

Qualitative analysis and reproducibility assessment of the ..:

Wang, Yao ; Coyne, Karin ; Sofen, Howard...
Journal of Dermatological Treatment.  30 (2019)  8 - p. 775-783 , 2019
 
?
 
?
14

Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in..:

Krock, Emerson ; Currie, J. Brooke ; Weber, Michael H....
Journal of Biological Chemistry.  291 (2016)  7 - p. 3541-3551 , 2016
 
?
15

Toll-like Receptor 2 Regulates Nerve Growth Factor Synthesi..:

Krock, Emerson ; Currie, J. Brooke ; Weber, Michael H....
Global Spine Journal.  6 (2016)  1_suppl - p. s-0036-1582634-s-0036-1582634 , 2016
 
1-15